The Effect of A1 Adenosine Receptor in Diabetic Megalin Loss with Caspase-1/IL18 Signaling [Corrigendum]
Tian D, Shi X, Zhao Y, et al. Diabet Metab Syndr Obes. 2019;12:1583– 1596.The authors of this paper have advised that Figures 5 and 6 are incorrect. The authors provided only one actin control for each treatment. However, their different target proteins had their own matched actin from the...
Guardado en:
Autores principales: | Tian D, Shi X, Zhao Y, Peng X, Zou L, Xu L, Ma Y, Wen Y, Faulhaber-Walter R, Chen L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c37fe1d489b4634b980db0b06fc5dbb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The effect of A1 adenosine receptor in diabetic megalin loss with caspase-1/IL18 signaling
por: Tian D, et al.
Publicado: (2019) -
New Insights into the Roles of Megalin/LRP2 and the Regulation of its Functional Expression
por: Marzolo,María-Paz, et al.
Publicado: (2011) -
Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
por: Rafael Franco, et al.
Publicado: (2021) -
Cerebral A1 adenosine receptor availability in female and male participants and its relationship to sleep
por: Anna L. Pierling, et al.
Publicado: (2021) -
Caspase-1 Inhibitor Reduces Pyroptosis Induced by Brain Death in Kidney
por: Weifeng Liu, et al.
Publicado: (2021)